| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Students, Pharmacy | 12 | 2024 | 63 | 5.150 |
Why?
|
| Education, Pharmacy | 11 | 2024 | 54 | 4.720 |
Why?
|
| Nonprescription Drugs | 18 | 2018 | 46 | 4.250 |
Why?
|
| Drug Labeling | 11 | 2018 | 26 | 3.140 |
Why?
|
| Prescription Drugs | 7 | 2023 | 52 | 2.180 |
Why?
|
| Health Expenditures | 5 | 2024 | 103 | 1.650 |
Why?
|
| Healthcare Disparities | 3 | 2025 | 417 | 1.470 |
Why?
|
| Pharmacists | 13 | 2013 | 83 | 1.390 |
Why?
|
| Students | 4 | 2021 | 251 | 1.350 |
Why?
|
| United States | 35 | 2025 | 10651 | 1.310 |
Why?
|
| Cross-Sectional Studies | 26 | 2025 | 3371 | 1.290 |
Why?
|
| Educational Measurement | 6 | 2024 | 324 | 1.170 |
Why?
|
| Medicare Part C | 2 | 2016 | 35 | 1.030 |
Why?
|
| Health Services Accessibility | 3 | 2025 | 593 | 1.030 |
Why?
|
| School Admission Criteria | 3 | 2023 | 21 | 1.000 |
Why?
|
| Adult | 40 | 2025 | 29010 | 0.990 |
Why?
|
| Surveys and Questionnaires | 18 | 2024 | 3666 | 0.950 |
Why?
|
| Medication Adherence | 3 | 2023 | 387 | 0.940 |
Why?
|
| Curriculum | 3 | 2024 | 718 | 0.930 |
Why?
|
| Schools, Pharmacy | 5 | 2024 | 22 | 0.900 |
Why?
|
| Life Change Events | 2 | 2023 | 59 | 0.890 |
Why?
|
| Chiropractic | 1 | 2023 | 1 | 0.870 |
Why?
|
| Manipulation, Chiropractic | 1 | 2023 | 1 | 0.870 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2016 | 254 | 0.850 |
Why?
|
| Humans | 80 | 2025 | 123072 | 0.830 |
Why?
|
| Medicare Part D | 2 | 2020 | 17 | 0.820 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 1230 | 0.820 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2020 | 591 | 0.810 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 1862 | 0.800 |
Why?
|
| Health Status Disparities | 1 | 2024 | 219 | 0.790 |
Why?
|
| Complementary Therapies | 2 | 2013 | 42 | 0.770 |
Why?
|
| Female | 48 | 2025 | 65528 | 0.760 |
Why?
|
| Texas | 19 | 2024 | 3563 | 0.760 |
Why?
|
| Attitude of Health Personnel | 5 | 2016 | 641 | 0.740 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2024 | 239 | 0.740 |
Why?
|
| Health Status Indicators | 2 | 2014 | 120 | 0.720 |
Why?
|
| United States Food and Drug Administration | 9 | 2024 | 148 | 0.720 |
Why?
|
| Male | 45 | 2025 | 60081 | 0.720 |
Why?
|
| Retrospective Studies | 16 | 2025 | 16039 | 0.720 |
Why?
|
| Self Medication | 5 | 2012 | 23 | 0.710 |
Why?
|
| Diabetes Complications | 1 | 2022 | 196 | 0.710 |
Why?
|
| Health Status | 3 | 2024 | 374 | 0.710 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 332 | 0.700 |
Why?
|
| Aged | 25 | 2025 | 19094 | 0.700 |
Why?
|
| Pharmacy | 1 | 2020 | 13 | 0.700 |
Why?
|
| Perception | 5 | 2016 | 219 | 0.690 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2022 | 420 | 0.680 |
Why?
|
| Medication Therapy Management | 2 | 2016 | 25 | 0.670 |
Why?
|
| Middle Aged | 30 | 2025 | 25992 | 0.670 |
Why?
|
| Interviews as Topic | 2 | 2018 | 367 | 0.650 |
Why?
|
| Immunotherapy | 1 | 2024 | 662 | 0.640 |
Why?
|
| Universities | 3 | 2018 | 126 | 0.630 |
Why?
|
| Intention | 4 | 2022 | 91 | 0.630 |
Why?
|
| Quality of Life | 3 | 2015 | 1928 | 0.620 |
Why?
|
| Psychological Theory | 3 | 2016 | 32 | 0.610 |
Why?
|
| Cognition | 3 | 2018 | 736 | 0.610 |
Why?
|
| Health Services | 1 | 2018 | 71 | 0.600 |
Why?
|
| Patient Compliance | 3 | 2015 | 466 | 0.600 |
Why?
|
| Academic Performance | 1 | 2017 | 18 | 0.580 |
Why?
|
| Consumer Behavior | 3 | 2004 | 39 | 0.580 |
Why?
|
| Patient Education as Topic | 4 | 2017 | 452 | 0.580 |
Why?
|
| Pamphlets | 1 | 2017 | 23 | 0.570 |
Why?
|
| Ephedrine | 2 | 2008 | 5 | 0.570 |
Why?
|
| Reading | 1 | 2018 | 80 | 0.570 |
Why?
|
| Disabled Children | 1 | 2017 | 25 | 0.550 |
Why?
|
| Young Adult | 16 | 2025 | 8836 | 0.550 |
Why?
|
| Clinical Pharmacy Information Systems | 3 | 2006 | 20 | 0.540 |
Why?
|
| Early Detection of Cancer | 2 | 2016 | 349 | 0.500 |
Why?
|
| Prescription Drug Overuse | 1 | 2015 | 3 | 0.490 |
Why?
|
| Drug Information Services | 4 | 2004 | 7 | 0.490 |
Why?
|
| Medication Systems, Hospital | 4 | 2011 | 42 | 0.480 |
Why?
|
| Visually Impaired Persons | 2 | 2012 | 7 | 0.470 |
Why?
|
| Nursing Staff, Hospital | 2 | 2012 | 60 | 0.470 |
Why?
|
| Social Class | 1 | 2015 | 191 | 0.460 |
Why?
|
| Learning | 1 | 2017 | 361 | 0.460 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 1591 | 0.460 |
Why?
|
| Mental Disorders | 1 | 2021 | 820 | 0.440 |
Why?
|
| Formularies as Topic | 2 | 2004 | 2 | 0.440 |
Why?
|
| Parenting | 1 | 2017 | 328 | 0.420 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 426 | 0.420 |
Why?
|
| Public Opinion | 1 | 2013 | 56 | 0.410 |
Why?
|
| Drugs, Generic | 4 | 2013 | 13 | 0.410 |
Why?
|
| Consumer Health Information | 1 | 2012 | 25 | 0.400 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2012 | 69 | 0.400 |
Why?
|
| Communication | 1 | 2016 | 513 | 0.400 |
Why?
|
| Demography | 2 | 2023 | 239 | 0.400 |
Why?
|
| Achievement | 2 | 2015 | 32 | 0.400 |
Why?
|
| Professional Role | 5 | 2013 | 57 | 0.400 |
Why?
|
| Efficiency | 1 | 2012 | 58 | 0.390 |
Why?
|
| Stress, Psychological | 1 | 2017 | 555 | 0.390 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 481 | 0.380 |
Why?
|
| Exercise | 1 | 2017 | 812 | 0.380 |
Why?
|
| Chronic Disease | 1 | 2016 | 1161 | 0.380 |
Why?
|
| Body Mass Index | 1 | 2017 | 1549 | 0.380 |
Why?
|
| Acetaminophen | 1 | 2012 | 91 | 0.380 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2012 | 105 | 0.380 |
Why?
|
| Attitude to Health | 1 | 2013 | 259 | 0.380 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2024 | 826 | 0.370 |
Why?
|
| Education, Pharmacy, Graduate | 2 | 2024 | 4 | 0.370 |
Why?
|
| Behind-the-Counter Drugs | 1 | 2011 | 1 | 0.370 |
Why?
|
| Emigrants and Immigrants | 1 | 2013 | 144 | 0.370 |
Why?
|
| Pseudomonas Infections | 1 | 2011 | 116 | 0.360 |
Why?
|
| Socioeconomic Factors | 3 | 2025 | 863 | 0.360 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 166 | 0.350 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2019 | 713 | 0.340 |
Why?
|
| Drug and Narcotic Control | 3 | 2019 | 18 | 0.340 |
Why?
|
| Cost of Illness | 1 | 2011 | 242 | 0.340 |
Why?
|
| Hospitalization | 1 | 2018 | 1728 | 0.340 |
Why?
|
| Legislation, Drug | 2 | 2008 | 9 | 0.340 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2010 | 33 | 0.340 |
Why?
|
| Pharmaceutical Services | 2 | 2016 | 35 | 0.340 |
Why?
|
| Health Surveys | 2 | 2008 | 241 | 0.330 |
Why?
|
| Hematinics | 1 | 2010 | 57 | 0.330 |
Why?
|
| Cystic Fibrosis | 1 | 2011 | 257 | 0.320 |
Why?
|
| Physicians | 6 | 2019 | 583 | 0.310 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 848 | 0.310 |
Why?
|
| Health Behavior | 3 | 2017 | 381 | 0.300 |
Why?
|
| Pseudoephedrine | 1 | 2008 | 1 | 0.300 |
Why?
|
| Hydrocodone | 2 | 2019 | 35 | 0.290 |
Why?
|
| Consumer Product Safety | 2 | 2004 | 29 | 0.290 |
Why?
|
| Pharmaceutical Preparations | 2 | 2005 | 79 | 0.290 |
Why?
|
| Drug Packaging | 2 | 2005 | 7 | 0.280 |
Why?
|
| Cohort Studies | 3 | 2024 | 4703 | 0.280 |
Why?
|
| Community Participation | 2 | 2012 | 44 | 0.280 |
Why?
|
| Cost-Benefit Analysis | 2 | 2010 | 500 | 0.270 |
Why?
|
| Lymphoma | 1 | 2010 | 324 | 0.270 |
Why?
|
| Drug Prescriptions | 3 | 2006 | 218 | 0.270 |
Why?
|
| Age Factors | 4 | 2025 | 2803 | 0.270 |
Why?
|
| Drug Industry | 2 | 2004 | 45 | 0.270 |
Why?
|
| Community Pharmacy Services | 4 | 2013 | 10 | 0.260 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2006 | 27 | 0.260 |
Why?
|
| Language | 1 | 2007 | 202 | 0.260 |
Why?
|
| Methamphetamine | 1 | 2006 | 32 | 0.260 |
Why?
|
| Anemia | 1 | 2010 | 340 | 0.260 |
Why?
|
| Medicare | 2 | 2020 | 424 | 0.260 |
Why?
|
| Insurance, Pharmaceutical Services | 2 | 2012 | 10 | 0.250 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 125 | 0.250 |
Why?
|
| Adolescent | 13 | 2018 | 19096 | 0.250 |
Why?
|
| Electronic Health Records | 1 | 2012 | 707 | 0.250 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2005 | 23 | 0.240 |
Why?
|
| Doping in Sports | 1 | 2005 | 7 | 0.240 |
Why?
|
| Hair Follicle | 1 | 2005 | 34 | 0.240 |
Why?
|
| Substance Abuse Detection | 1 | 2005 | 42 | 0.240 |
Why?
|
| Motivation | 1 | 2006 | 314 | 0.230 |
Why?
|
| Computers | 1 | 2004 | 67 | 0.230 |
Why?
|
| Marijuana Abuse | 1 | 2024 | 48 | 0.230 |
Why?
|
| Drug Approval | 1 | 2024 | 40 | 0.220 |
Why?
|
| Blindness | 1 | 2004 | 72 | 0.220 |
Why?
|
| Histamine H1 Antagonists | 1 | 2003 | 12 | 0.220 |
Why?
|
| Analgesics, Opioid | 2 | 2019 | 403 | 0.220 |
Why?
|
| Societies, Pharmaceutical | 1 | 2003 | 11 | 0.220 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2003 | 24 | 0.220 |
Why?
|
| Job Satisfaction | 1 | 2004 | 78 | 0.220 |
Why?
|
| Neck Pain | 1 | 2023 | 19 | 0.210 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 2480 | 0.210 |
Why?
|
| Back Pain | 1 | 2023 | 27 | 0.210 |
Why?
|
| Heart Diseases | 1 | 2008 | 482 | 0.210 |
Why?
|
| Prescription Fees | 2 | 2013 | 3 | 0.210 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 180 | 0.210 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 310 | 0.210 |
Why?
|
| Comprehension | 2 | 2017 | 77 | 0.210 |
Why?
|
| Pharmacies | 1 | 2022 | 13 | 0.210 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2003 | 165 | 0.210 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2004 | 266 | 0.200 |
Why?
|
| Internet | 1 | 2005 | 378 | 0.200 |
Why?
|
| Community Health Centers | 2 | 2012 | 39 | 0.200 |
Why?
|
| Psychometrics | 2 | 2017 | 657 | 0.190 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2023 | 162 | 0.190 |
Why?
|
| Academic Success | 1 | 2021 | 20 | 0.190 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 6371 | 0.180 |
Why?
|
| HIV Infections | 3 | 2014 | 1855 | 0.180 |
Why?
|
| College Admission Test | 1 | 2020 | 4 | 0.180 |
Why?
|
| Controlled Substances | 2 | 2019 | 12 | 0.180 |
Why?
|
| Computers, Handheld | 2 | 2010 | 33 | 0.170 |
Why?
|
| Patient Care Team | 1 | 2003 | 548 | 0.160 |
Why?
|
| Acute Pain | 1 | 2019 | 21 | 0.160 |
Why?
|
| Databases, Factual | 3 | 2016 | 1171 | 0.160 |
Why?
|
| Anxiety | 2 | 2021 | 956 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2020 | 121 | 0.160 |
Why?
|
| Health Care Surveys | 5 | 2019 | 284 | 0.150 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2826 | 0.150 |
Why?
|
| Patient Participation | 2 | 2017 | 220 | 0.150 |
Why?
|
| Data Collection | 4 | 2007 | 383 | 0.150 |
Why?
|
| Attitude | 2 | 2012 | 118 | 0.150 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 1412 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2004 | 994 | 0.140 |
Why?
|
| Logistic Models | 3 | 2018 | 1798 | 0.140 |
Why?
|
| Vaccines | 1 | 2022 | 370 | 0.140 |
Why?
|
| Chronic Pain | 1 | 2019 | 127 | 0.140 |
Why?
|
| Medication Errors | 3 | 2011 | 184 | 0.140 |
Why?
|
| Arabs | 1 | 2015 | 29 | 0.130 |
Why?
|
| Watchful Waiting | 1 | 2016 | 65 | 0.130 |
Why?
|
| Nursing Evaluation Research | 2 | 2012 | 7 | 0.130 |
Why?
|
| Tobacco Products | 1 | 2015 | 61 | 0.120 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 477 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2011 | 1008 | 0.120 |
Why?
|
| Forecasting | 1 | 2016 | 354 | 0.120 |
Why?
|
| Parent-Child Relations | 1 | 2017 | 250 | 0.120 |
Why?
|
| Pharmacy Service, Hospital | 2 | 2006 | 49 | 0.120 |
Why?
|
| Choice Behavior | 1 | 1996 | 131 | 0.120 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 1305 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2016 | 3317 | 0.120 |
Why?
|
| Mammography | 1 | 2015 | 113 | 0.120 |
Why?
|
| Workflow | 2 | 2011 | 114 | 0.110 |
Why?
|
| Smoking Cessation | 1 | 2015 | 196 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2016 | 383 | 0.110 |
Why?
|
| Phytotherapy | 1 | 2013 | 50 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2015 | 356 | 0.100 |
Why?
|
| Diagnosis-Related Groups | 1 | 2012 | 28 | 0.100 |
Why?
|
| Medical Assistance | 1 | 2012 | 6 | 0.100 |
Why?
|
| Time Management | 2 | 2015 | 11 | 0.100 |
Why?
|
| Risk Factors | 2 | 2016 | 10016 | 0.100 |
Why?
|
| Self Report | 1 | 2015 | 509 | 0.100 |
Why?
|
| Child, Preschool | 3 | 2022 | 13881 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 423 | 0.090 |
Why?
|
| Nurses | 1 | 2011 | 63 | 0.090 |
Why?
|
| Risk | 1 | 2012 | 745 | 0.090 |
Why?
|
| Prospective Studies | 5 | 2011 | 6027 | 0.080 |
Why?
|
| Educational Status | 2 | 2015 | 270 | 0.080 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 823 | 0.080 |
Why?
|
| Neoplasms | 1 | 2023 | 2758 | 0.080 |
Why?
|
| Attitude to Computers | 2 | 2010 | 49 | 0.080 |
Why?
|
| Health Policy | 1 | 2010 | 213 | 0.070 |
Why?
|
| Commerce | 1 | 2008 | 51 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 937 | 0.070 |
Why?
|
| Child | 3 | 2022 | 24226 | 0.070 |
Why?
|
| Test Anxiety Scale | 1 | 2006 | 2 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 228 | 0.070 |
Why?
|
| Length of Stay | 1 | 2012 | 1289 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2016 | 1158 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2010 | 1473 | 0.070 |
Why?
|
| Time and Motion Studies | 3 | 2011 | 21 | 0.060 |
Why?
|
| Academic Medical Centers | 2 | 2006 | 300 | 0.060 |
Why?
|
| Models, Psychological | 2 | 2016 | 135 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 1310 | 0.060 |
Why?
|
| Personal Satisfaction | 1 | 2006 | 102 | 0.060 |
Why?
|
| Medical Order Entry Systems | 1 | 2006 | 98 | 0.060 |
Why?
|
| Poverty | 3 | 2013 | 418 | 0.060 |
Why?
|
| Social Behavior | 1 | 2006 | 207 | 0.060 |
Why?
|
| Placebos | 1 | 2005 | 238 | 0.060 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2004 | 31 | 0.060 |
Why?
|
| Human Genome Project | 1 | 2004 | 55 | 0.060 |
Why?
|
| Spain | 1 | 2004 | 53 | 0.060 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 1 | 2003 | 3 | 0.060 |
Why?
|
| Diphenhydramine | 1 | 2003 | 10 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 455 | 0.060 |
Why?
|
| Managed Care Programs | 1 | 2004 | 61 | 0.060 |
Why?
|
| Hospital Information Systems | 1 | 2003 | 43 | 0.050 |
Why?
|
| Disease Progression | 1 | 2010 | 2023 | 0.050 |
Why?
|
| Home Care Services | 1 | 2003 | 67 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2004 | 183 | 0.050 |
Why?
|
| Bioethics | 1 | 2004 | 70 | 0.050 |
Why?
|
| Algorithms | 1 | 2010 | 1592 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2003 | 153 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 197 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 1308 | 0.050 |
Why?
|
| Psychomotor Performance | 1 | 2003 | 182 | 0.050 |
Why?
|
| Health Services Research | 1 | 2004 | 186 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2003 | 135 | 0.050 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2003 | 122 | 0.050 |
Why?
|
| Periodicals as Topic | 1 | 2004 | 195 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 1660 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2002 | 229 | 0.040 |
Why?
|
| Faculty | 1 | 2021 | 100 | 0.040 |
Why?
|
| Teaching | 1 | 2021 | 183 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2003 | 656 | 0.040 |
Why?
|
| Quality Control | 1 | 1999 | 119 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2019 | 269 | 0.040 |
Why?
|
| Analgesics | 1 | 2019 | 135 | 0.040 |
Why?
|
| Truth Disclosure | 1 | 1999 | 103 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 258 | 0.040 |
Why?
|
| Program Evaluation | 2 | 2012 | 450 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 947 | 0.040 |
Why?
|
| Mental Processes | 1 | 1997 | 41 | 0.030 |
Why?
|
| United States Government Agencies | 1 | 2016 | 5 | 0.030 |
Why?
|
| Infant | 1 | 2011 | 12355 | 0.030 |
Why?
|
| Performance Anxiety | 1 | 2015 | 1 | 0.030 |
Why?
|
| Nigeria | 1 | 2015 | 79 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 1072 | 0.030 |
Why?
|
| Office Visits | 1 | 2016 | 77 | 0.030 |
Why?
|
| Parents | 1 | 2022 | 1031 | 0.030 |
Why?
|
| Professional-Patient Relations | 1 | 1996 | 85 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 2016 | 131 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2016 | 138 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 1996 | 172 | 0.030 |
Why?
|
| Counseling | 1 | 1996 | 219 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2016 | 375 | 0.030 |
Why?
|
| Awareness | 1 | 2013 | 81 | 0.030 |
Why?
|
| Nursing Records | 1 | 2011 | 5 | 0.020 |
Why?
|
| Decision Making | 1 | 1997 | 651 | 0.020 |
Why?
|
| Cost Savings | 1 | 2012 | 69 | 0.020 |
Why?
|
| Heart Failure | 1 | 2003 | 2127 | 0.020 |
Why?
|
| Patient Care | 1 | 2011 | 100 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1256 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2012 | 365 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2011 | 391 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 767 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2011 | 483 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 586 | 0.020 |
Why?
|
| Telefacsimile | 1 | 2006 | 1 | 0.020 |
Why?
|
| Systems Integration | 1 | 2006 | 27 | 0.020 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2006 | 49 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 648 | 0.020 |
Why?
|
| Home Care Agencies | 1 | 2003 | 1 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 6222 | 0.010 |
Why?
|